All submissions to the ERR are handled via the ScholarOne Manuscripts platform, which provides detailed instructions of how to follow the submission process. If you experience problems or require any further assistance, please contact the submission helpline direct on +44 114 2672864.
The following table of contents can be used to navigate these instructions.
Overlapping publications and publications ethics
Review and Series articles
Online supplementary data
Permission to reproduce materials
Conflict of interest
Requirements for sponsored publication
Further information and enquiries
Authors submitting a paper to the European Respiratory Review do so on the understanding that neither the work nor any part of its essential substance, tables or figures have been or will be published or submitted to another scientific journal or is being considered for publication elsewhere. This must be stated in the covering letter. This restriction does not apply to abstracts, but includes work published in another language.
It is the authors' responsibility to ensure that submitted manuscripts are not duplicate publications; any simultaneous submissions of similar or related manuscripts must be declared at the point of submission and electronic copies of the manuscripts in question included as a supplement to your manuscript files. If there are any concerns following submission, the editors reserve the right to take appropriate action.
As a member of the Committee on Publication Ethics, the ERR follows the COPE codes of conduct and best practice guidelines.
Presentation of manuscripts should be consistent with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, as recommended by the International Committee of Medical Journal Editors (ICMJE).
All manuscripts must be submitted electronically using the online submission at ScholarOne Manuscripts. Detailed instructions of how to submit are available on the website itself and the process is self-explanatory. However, if you do experience problems, please contact the submission helpline direct on +44 114 2672864.
Before entering the ERR ScholarOne online submission area, please read and carefully follow the instructions below.
Brief requirements for articles are summarised in the following table. Further details can be found in the relevant sections below.
|Update, reviews and series articles||5000||5||150||Yes||Yes, 200 words|
|Mini-review articles||2500||4||50||Yes||Yes, 200 words|
The number of figures and tables in the above summary refers to the total number of both; for example, correspondence can have one figure or one table, not one of each.
- The manuscript file you submit must be saved as .rtf (rich text format) or .doc (MS Word document).
- Abbreviations and unusual terms should be described at the first time of use.
- Symbols as defined by the ad hoc working group of the Commission of the European Communities (see Eur Respir J 1993; 6: Suppl. 16) are recommended.
- The manuscript should be written in UK English.
- Système International (SI) units are recommended.
- Equations should be created as normal text.
- Please provide a concise and informative title, limited to 90 characters, including spaces between words.
- Include a list of all contributing authors and all of their affiliations, with a clear indication of who is associated with each institution.
- Supply the full correspondence details for the corresponding author, including e-mail address. Please note that only one corresponding author per manuscript should be provided.
- Provide a 115-character (including spaces) summary of the "take home" message of your paper, which can be used to publicise your study via social media.
- Tables should be created and inserted into the text document using the 'Table', 'Insert Table'; function in your word processing package. Do not supply tables in a separate file.
- Tables should be numbered consecutively with Arabic numerals.
- Limit data to a sensible number of significant figures.
- Large tables should be avoided if possible. Due to space restrictions, they may need to be split for print publication.
- Please provide a clear footnote for each table, making sure all abbreviations and symbols used are defined.
- For reference numbering schemes, citations made in tables should continue in numerical order from the point in the main body text where the table is cited.
- Line-art figures should preferably be supplied in JPEG, TIFF, Adobe Illustrator (.ai), PDF, SVG, or EPS format.
- Halftone and photographic images must be supplied in PSD, JPEG or TIFF format. Minimum resolution should be 300 dpi at the final print size.
- Images embedded in the .doc or .rtf file, or saved as .ppt files, will not be accepted.
Size and quantity
- Figures should be limited (both in size and number) to those required to show the essential features described in the manuscript.
- Large figures comprising many individual parts should be avoided: as a maximum, each individual figure must fit to a single print page of the journal, with sufficient space for its accompanying caption.
- Redundant or excessive figures will not be published due to space restrictions; such figures will be presented as online supplementary material.
- Images should be submitted in as close a size as possible to the final print size. There are three size options: 88, 137 or 188 mm.
- All submitted figures must be clearly named and numbered.
- Whether for images, drawings or graphs, no more than four components should be used for a given figure. These should be labelled as a), b), c) and d).
- Due to space restrictions, it is essential that each submitted figure show only the areas of interest with enough surrounding area for orientation purposes.
- Radiographic images should be of high quality and combined into one array, such as posteroanterior and lateral views. They should also be sized the same to facilitate reproduction.
- When several images of a given type are being shown, please reproduce all at the same magnification.
- Photomicrographs must have internal linear scale markers (scale bars), since the size and magnification may be altered by the publisher or by the reader’s monitor/display.
- Images should correspond in appearance to the tonal relations of the original radiograph (i.e. showing the bones white on a dark background), with the patient's right to the observer's left. CT scans and magnetic resonance images should employ the internationally-accepted 'view from below'.
- Please label your images such that all important details are clearly visible. Avoid obscuring large areas of the images with excessive labelling.
- Use a sans serif font for all labelling (preferably Arial), and ensure that the font size is reasonable and uniform throughout all the figures in your manuscript.
- Please ensure that bar charts and graphs have a white background, with no shading or gridlines.
- Use greyscale shading on bar charts and graphs (different weights can be used, e.g. from 0% (white) to 100% (black) for purposes of differentiation), in preference to hatching and patterning.
- Three-dimensional effects should not be used in the presentation of bar charts.
- For reference numbering schemes, citations made in figures should continue in numerical order from the point in the main body text where the figure is cited.
Guidelines for handling image data
- If an image has been enhanced electronically, please explain the alterations that have been made and submit the original image along with the enhanced one. Moreover, keep an electronic set of original images, since our reviewers might ask you to modify their content and the display modus.
- The Council of Science Editors (CSE) has established four basic guidelines for handling image data, which authors submitting to the ERR are urged to comply with. 1) No specific feature within an image may be enhanced, obscured, removed or introduced. 2) Adjustments of brightness, contrast or colour balance are acceptable if they are applied to the whole image and as long as they do not obscure, eliminate or misrepresent any information present in the original. 3) The grouping of images from different parts of the same gel, or from different gels, fields or exposures must be made explicit by the arrangement of the figure (e.g. dividing lines) and in the text of the figure legend. 4) If the original data cannot be produced by an author when asked to provide it, the acceptance of the manuscript may be revoked.
- Please provide a clear caption for each figure.
- Captions should be brief and not repetitive of information given in the text.
- Where appropriate, they should include the imaging technique used, the body part imaged and any noteworthy details.
- All abbreviations should be expanded.
- Use of internal scales should be mentioned.
- All acknowledgements should be grouped into one paragraph placed after the Discussion section.
- Only acknowledge persons who have made substantial contributions, and provide the affiliation of those you name.
- Provide the names and affiliation details of members of collaborating bodies.
- Financial support should be acknowledged in a separate support statement; financial support provided to individuals must be disclosed on the conflict of interest declaration.
- Number references consecutively in the order in which they first appear in the text, using full size Arabic numerals in square brackets to cite references.
- All authors must be included for each cited item.
- References should conform to the style used in Index Medicus (Vancouver style) as shown in the following examples:
1. Bannerjee D, Khair OA, Honeybourne D. Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD. Eur Respir J 2004; 23: 685-692.
2. Bourbon J, Henrion-Caude A, Gaultier C. Molecular basis of lung development. In: Gibson GJ, Geddes DM, Costable U, Sterk PJ, Corrin B, eds. Respiratory Medicine. 3rd Edn. Edinburgh/Philadelphia, Elsevier Science, 2002; pp. 64-81.
- Sources published as websites should be listed in the reference list, not in the text, and only used when an original citation is unavailable; citations should be listed as follows (include the author of the webpage, its title, the URL on which the cited material can be found, and the dates on which the webpage was last accessed by you, and on which it was last updated):
3. WHO. Severe Acute Respiratory Syndrome (SARS). www.who.int/csr/sars/en/index.html. Date last updated: June 1 2004. Date last accessed: June 1 2004.
- Citations made in figures or tables should continue in numerical order from the point in the main body text where the figure/table is cited.
- Works that have not yet been accepted for publication and personal communications should not appear in the reference list.
- A copy of any paper cited as "in press" should be uploaded to the ScholarOne submission platform as supplementary material, if at the time of submission they are not yet (or will not be) published online ahead of print.
For further general guidance on how to write papers, please refer to: Sterk PJ, Rabe KF. The joy of writing a paper. Breathe 2008; 4: 224-232, and guidelines for authors on how to write scientific articles to be published in English at http://www.ease.org.uk/publications/author-guidelines
Review articles provide an overview and discussion of recent and current studies/practices in a particular area of respiratory research.
They should include an abstract of no more than 200 words in length, which provides an overview of the full article and which is easily understood without reference to the text.
Review articles should not exceed 5000 words in length (you do not need to include abstract, references, tables and figure captions in this word count); if manuscripts exceed this limit, please state the final word count and explicit reasons for exceeding the limit in your covering letter.
Review articles can include a maximum of five figures and/or tables (i.e. any combination of tables and figures up to a total of five overall, not five figures and five tables).
Given the nature of review articles, it is appropriate to include a higher number of references than in original articles, but this should not exceed 150 references in total.
Correspondence can be submitted for discussion of recently published articles and other topical matters.
Correspondence should not exceed 1200 words (you do not need to include references, tables and figure captions in this word count), should have no more than 12 references and should not include more than one figure or one table.
The European Respiratory Review will not publish online supplementary material for correspondence.
Authors have the option of providing supplementary data or figures, and accompanying videos, as an online supplement. This is an optional function and can be used at the discretion of the author and/or editor. The European Respiratory Review will not accept supplementary material for editorials, letters or correspondence. Documents should be uploaded as "Supplementary material" during the submission process.
Videos to be presented as part of the online depository should be supplied in one of the following formats: Quicktime; MPEG; Microsoft AVI; Windows media video; Shockwave Flash.
Authors should note that their supplementary material will not be edited by the publications office, and will be published online as it is supplied.
The European Respiratory Review discourages the use of previously published figures and tables, or any other material previously published elsewhere, unless absolutely essential. If it is essential that such material be included in your manuscript, you must obtain permission from the copyright owner before you submit your manuscript to the ERR. The copyright owner is usually the publisher, and not the original author. Please note that in order to secure the re-use of the material in question, you may be required to pay a fee to the original publisher. Furthermore, some publishers will not provide permission for publication, which precludes the material from being published in the printed and online versions of the ERR.
Authors should be aware that externally produced questionnaires are often copyrighted, meaning that their use, reproduction and modification may be restricted. Before using, modifying or reproducing questionnaires, you should contact the copyright holder (the individual/group credited with creation of the questionnaire) to seek their support and gain written permission for reproduction and/or modification of the questionnaire, as necessary. If you are unsure about usage, modification and reproduction of questionnaires, you should contact the copyright holder/creator of the questionnaire in the first instance. Should concerns arise regarding the use, reproduction and modification of questionnaires, the ERR reserves the right to take appropriate action.
Once your manuscript has been accepted for publication, the ERR publications team will contact you requesting that all the written permission agreements you have obtained are forwarded to the office for our records.
There is no maximum for the number of authors of a manuscript, although all work must have been approved by all co-authors.
Authorship credit should be based on fulfillment of all of the following four criteria:
1) substantial contributions to either: the conception and design of the work; or the acquisition, analysis or interpretation of data for the work; and
2) drafting the article or revising it critically for important intellectual content; and
3) final approval of the version to be published; and
4) agreement to be accountable for all aspects of the work, in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
All persons designated as authors should qualify for authorship, and all those who qualify should be listed.
Acquisition of funding, collection of data, or general supervision of the research group does not justify authorship.
Writing assistance from medical writers or agencies must be included in the acknowledgements section, or should be given appropriate credit as authorship.
As manuscripts must have been approved by all authors prior to submission, any changes to the list of authors that are proposed after manuscript submission will require written approval from all named authors; this is in accord with the procedures outlined by the Committee on Publications Ethics (COPE).
Submission of the manuscript implies that if and when it is accepted for publication, the authors automatically agree to transfer the copyright to the publisher. The copyright protection implies that the publisher holds the exclusive right to reproduction in any form (including publication in another language) and distribution of any of the articles in the ERR. Material published in the European Respiratory Review may not be stored in any electronic format, or be reproduced photographically, except with the prior written permission of the publisher.
All ERR papers are free to read, share and reuse for non-commercial purposes under the CC-BY-NC 4.0 licence.
In the event that the paper is accepted for publication, all authors will be contacted and asked to complete an online form transferring copyright to ERS. All authors must complete this online form before the paper can be published.
Although the ERR is an open access journal, there are no article processing charges for non-sponsored articles.
Authors of ERR articles are entitled to deposit the final published version of their manuscripts in a non-commercial institutional (or other) repository for public archiving immediately upon publication.
On submission of your manuscript, you will be notified by e-mail on receipt of the submitted online draft and provided with a manuscript number for future reference.
Each manuscript will be reviewed by the Chief Editor. Manuscripts will be subjected to peer review by external reviewers. After your manuscript has been reviewed, you may be requested to make changes to your manuscript arising from reviewer comments. When submitting your revised manuscript, two copies must be provided: one clean copy of the revised manuscript, and one copy in which all of the text added as a result of reviewer comments is highlighted in red.
The reviewers will recommend their decisions to the Chief Editor, who will then be responsible for the final decision to accept or reject a manuscript.
If your manuscript is rejected after peer review, and you wish to appeal the decision, please e-mail a letter of rebuttal to: [email protected]
In the appeal letter, you should clearly state your name, the title of your manuscript and the manuscript number. Furthermore, it will help us to handle your appeal if you can provide specific point-by-point responses to any comments made by the editors and reviewers in support of their original decision. We will respond to all appeals as soon as possible, but of course in some cases it may take some time to make a final decision. The decision of the Chief Editor is final and only one appeal will be considered per manuscript.
Any conflict of interest for a given manuscript and for all authors of a manuscript must be dealt with according to the statement of the International Committee of Medical Journal Editors (the 'Vancouver Group') as published in Lancet 1993; 341: 742. The reviewers of the European Respiratory Review must disclose to the Chief Editor any personal or financial relationship that could bias their opinion and decision in the peer-review process.
In the interests of transparency, all authors must complete the ICMJE conflict of interest form and these must be uploaded during electronic manuscript submission. The peer-review process will not commence before all authors have completed conflict of interest declaration forms.
The authors have to acknowledge all financial support for the work (including, but not limited to, support from pharmaceutical companies, medical device companies and electronic nicotine delivery system companies) and other financial or personal conflicts of interest that are both connected and unconnected with the work. It is each author's responsibility to fill in this form correctly. Each author must complete their own conflict of interest declaration form. Corresponding authors should not complete forms on behalf of other authors, but corresponding authors can upload forms for other authors once they have been completed. If multiple forms are uploaded by one author, it is recommended that all the forms are placed in a .zip file, and the resultant "zipped" folder uploaded. The ERR and the Chief Editor reserve the right to take appropriate action if these forms have not been filled in correctly. A statement reflecting the disclosures made will be added to the manuscript at publication, and any forms on which a potential conflict of interest is disclosed uploaded as a supplement to the online version of the manuscript.
The ERR and its Chief Editor adhere to the European Respiratory Society (ERS) policy on tobacco industry funding (http://ersnet.org/images/stories/pdf/Bylaws_adopted_in_BCN_2013.pdf). The ERS does not accept contributions from authors who are receiving funding from the tobacco industry or electronic nicotine delivery system companies that are wholly or partially owned by tobacco companies. Authors will be asked to disclose any funding and/or conflict of interest related to the tobacco industry. In the case of disclosure of a conflict of interest any time after January 1, 2000 by the person concerned, there will be a 5-year ban from the date of disclosure before that person is allowed to participate actively in an ERS event again. In the case of the discovery of a conflict of interest, which was not disclosed by the person concerned, there will be a ban for life from participating actively in any ERS activity, including all ERS publications and scientific and intellectual contributions of any type. The same principle will apply to any other real or perceived, direct or indirect links with the tobacco industry, such as the holding of shares, speaking at or attending meetings organised by the tobacco industry. Any person found to be maintaining a relationship (as defined above) with, or receiving funding from, the tobacco industry after January 1, 2013 will be banned for life from involvement in any ERS activity including, membership, all ERS publications, scientific and intellectual contributions of any type.
On manuscript submission, authors will be asked if they comply with this policy. If you have any queries regarding this, please contact the publications office.
Commercial interest, funding or sponsorship must be declared, and will be clearly indicated in the provenance section.
The publication should be of interest to members of the European Respiratory Society. Papers should be written in an easy-to-read fashion with ample use of figures and graphs. If a series of clinical trials is reported, for instance, with a new drug, the paper should provide at least a systematic review of all the studies with a general conclusion. A sponsor shall not in any way dictate or impact the editorial content of an issue. All manuscripts should be submitted for peer review.
For researchers and authors, social channels are an opportunity to boost the profile of their work, to explain it in less technical ways and to new audiences, to get immediate feedback from their peers and to discuss aspects of their scientific work that might not form part of their conventional published output. For more information refer to the ERS social media guide.
Errors in the ERR should be brought to the attention of the Chief Editor.
Any correction deemed significant by the Chief Editor will be published in the ERR at the earliest opportunity.
Before print publication, a proof will be sent by e-mail (pdf file) to the corresponding author. It should be corrected and returned to the ERR publications office within 48 hours by email. Late return will delay publication. Modification to proofs should be limited to typographical errors only.
European Respiratory Society
442 Glossop Road
Tel: 44 114 2672860
E-mail: [email protected]
This page was updated on 26 January, 2017